Clinical Practice Guidelines for the Appropriate Use of Psychotropic Medications in People Living with Dementia and in Residential Aged Care
Published by Professor Simon Bell on Apr 24, 2024
Monash University, Faculty of Pharmacy and Pharmaceutical Sciences
| ☏
made with
MAGIC
PICOS
PICO 80.1
Population
People living with dementiaIntervention
Second generation antipsychoticsComparator
PlaceboOutcomes
PICO 80.2
Population
People living with dementiaIntervention
First generation antipsychoticComparator
PlaceboOutcomes
PICO 80.3
Population
People living with dementiaIntervention
First generation antipsychoticsComparator
Second generation antipsychoticsOutcomes
PICO 90.1
Population
People living with dementia using antipsychoticsIntervention
Discontinuation of antipsychotic medicationComparator
Continuation of antipsychotic medicationOutcomes
PICO 100.1
Population
People living with dementiaIntervention
BenzodiazepinesComparator
No treatment or placeboOutcomes
PICO 110.1
Population
People living with dementiaIntervention
Discontinuation of benzodiazepinesComparator
Continuation of benzodiazepinesOutcomes
PICO 120.1
Population
People living with dementiaIntervention
AntidepressantsComparator
PlaceboOutcomes
PICO 130.1
Population
People living with dementiaIntervention
Discontinuation of antidepressantsComparator
Continuation of antidepressantsOutcomes
PICO 140.1
Population
People living with dementiaIntervention
Pro re nata (PRN) use of antipsychoticsComparator
Regular use of antipsychoticsOutcomes
PICO 150.1
Population
RACF residentsIntervention
Professional Education ProgramComparator
No intervention/usual care/controlOutcomes
PICO 150.2
Population
RACF residentsIntervention
Medication ReviewComparator
No intervention/usual care/controlOutcomes
View
made with
MAGIC